ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 77 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $273,830 | -15.7% | 351,064 | 0.0% | 0.08% | -4.5% |
| Q2 2023 | $324,734 | -15.1% | 351,064 | 0.0% | 0.09% | -22.6% |
| Q1 2023 | $382,660 | -25.3% | 351,064 | 0.0% | 0.12% | -20.1% |
| Q4 2022 | $512,553 | +36.0% | 351,064 | 0.0% | 0.14% | +42.6% |
| Q3 2022 | $377,000 | -36.9% | 351,064 | 0.0% | 0.10% | -38.0% |
| Q2 2022 | $597,000 | -17.4% | 351,064 | 0.0% | 0.16% | -13.3% |
| Q1 2022 | $723,000 | +41.5% | 351,064 | +157.6% | 0.19% | +46.9% |
| Q4 2021 | $511,000 | +151.7% | 136,266 | +446.0% | 0.13% | -20.5% |
| Q2 2016 | $203,000 | -71.6% | 24,955 | -71.7% | 0.16% | -73.9% |
| Q1 2016 | $716,000 | +23.4% | 88,100 | +83.2% | 0.62% | +19.5% |
| Q4 2015 | $580,000 | – | 48,100 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $1,501,250 | 2.44% |
| NEA Management Company, LLC | 17,079,779 | $18,616,958 | 1.29% |
| Endurant Capital Management LP | 1,660,835 | $1,810,310 | 0.93% |
| Matrix Capital Management Company, LP | 38,974,185 | $42,481,862 | 0.58% |
| Long Focus Capital Management, LLC | 5,435,439 | $5,924,629 | 0.34% |
| PFM Health Sciences, LP | 5,992,571 | $6,531,902 | 0.29% |
| Key Client Fiduciary Advisors, LLC | 321,155 | $350,059 | 0.22% |
| DAFNA Capital Management LLC | 351,064 | $382,660 | 0.12% |
| Rock Springs Capital Management LP | 2,787,845 | $3,038,751 | 0.07% |
| Baker Brothers Advisors | 9,830,877 | $10,715,656 | 0.06% |